(1) Institute for Prevention of Cardiovascular Disease, Ludwig-Maximilians-University, Munich, Germany; (2) University of Birmingham Centre for Cardiovascular Sciences, City Hospital Birmingham, UK

(1) St Antonius Center for Platelet function research, St Antonius Hospital Nieuwegein, The Netherlands; (2) Department of Cardiology, St Antonius Hospital Nieuwegein, The Netherlands

(1) Center for Translational Injury Research, Houston, Texas, USA; (2) Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (3) Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; (4) Johns Hopkins Anticoagulation Service and Outpatient Clinics, Baltimore, Maryland, USA; (5) Department of Surgery, University of Texas Health Science Center, Houston, Texas, USA

(1) Department of Hematology, Erasmus University Medical Center Rotterdam, the Netherlands; (2) Department of Clinical Oncology, Leiden University Medical Center, Leiden,; (3) Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands

(1) Section of Cardiovascular Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA; (2) Center for Membrane Biology, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Houston, Texas, USA; (3) Tianjin Institute of Neurology, Tianjin Medical University, General Hospital, Tianjin, China

(1) Vascular medicine unit, Department of internal medicine, University Hospital, Montpellier, France; (2) Research Unit EA2992, Montpellier 1 University, Montpellier, France; (3) Techniques de l’Ingénierie Médicale et de la Complexité (TIMC), Unité Mixte de Recherche 5525, Centre National de la Recherche Scientifique (CNRS), Université Joseph Fourier, Grenoble, France; (4) Clinical Investigation Center, University Hospital, Grenoble, France; (5) Vascular medicine Unit, Amiens University Hospital, Amiens, France; (6) Vascular medicine physician, Clapiers, France; (7) Vascular medicine physician, Selestat, France; (8) Vascular medicine physician, Bourgoin-Jallieu, France; (9) Division of Angiology and Haemostasis, Geneva University Hospital, Geneva, Switzerland; (10) Vascular Medicine Unit, University Hospital, Angers, France

(1) Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan; (2) Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan; (3) Department of Emergency Medicine, Mie University Graduate School of Medicine, Tsu, Japan; (4) Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine, Tsu, Japan; (5) Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan; (6) Department of Anesthesia, Mie University Graduate School of Medicine, Tsu, Japan; (7) Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan; (8) Department of Cardiovascular Surgery, Mie University Graduate School of Medicine, Tsu, Japan; (9) Department of Digestive Surgery, Mie University Graduate School of Medicine, Tsu, Japan

(1) Department of Haematology, Clínica Universitaria de Navarra, Pamplona, Navarra, Spain; (2) Department of Internal Medicine, Hospital Sant Jaume d’Olot, Gerona, Spain; (3) Department of Internal Medicine, Hospital General Universitario Gregorio Marañon, Madrid, Spain; (4) Department of Internal Medicine, Hospital Infanta Cristina, Madrid, Spain; (5) Department of Internal Medicine, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; (6) Department of Internal Medicine, Ospedale St. John, Rome, Italy; (7) Department of Internal Medicine, Hospital Universitario Germans Trials i Pujol, Badalona, Barcelona, Spain

(1) Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna, Austria; (2) The Core Unit for Medical Statistics and Informatics, Vienna, Austria

(1) Grupo de Estudo da Hemostasia e Trombose – GETHe/UFMG, Belo Horizonte, Brazil; (2) Prefeitura de Pará de Minas, Pará de Minas, Brazil; (3) Target M&E Consultoria, Belo Horizonte, Brazil; (4) Sulamérica, São Paulo, Brazil; (5) Fundação HEMOMINAS, Belo Horizonte, Brazil; (6) Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands; (7) Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

(1) Department of Haematology, North University Hospital, Marseille, France; (2) Department of Obstetrics, North University Hospital, Marseille, France; (3) Inserm UMR-S608, Aix-Marseille 2 University, Marseille, France; (4) Haematology Laboratory, University Hospital, Nîmes, France

(1) Tumor Biology & Angiogenesis Laboratory, Division of Hematology and Oncology, Innsbruck Medical University, Austria; (2) Institute of Pathology, University Hospital Basel, Basel, Switzerland; (3) Department of Internal Medicine V, Hematology and Oncology, Innsbruck Medical University, Innsbruck, Austria; (4) KMT Laboratory, Innsbruck Medical University, Innsbruck, Austria; (5) Institute of Medical and Chemical Laboratory Diagnostics (ZIMCL), University Hospital Innsbruck, Innsbruck, Austria

(1) Johns Hopkins University, Baltimore, Maryland, USA; (2) Sarawak General Hospital, Kuching, Malaysia; (3) University of Michigan, Ann Arbor, Michigan, USA; (4) University of New Mexico, Albuquerque, New Mexico, USA

(1) Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; (2) Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan

(1) Cardiovascular Medicine, University of Nottingham, Nottingham, UK; (2) Department of Bioscience, Astra Zeneca R&D Mölndal, Mölndal, Sweden

(1) Deutsches Herzzentrum and 1. Medizinische Klinik rechts der Isar, Technische Universität München, Munich, Germany

(1) Department of Anaesthesiology, Heart Centre Bad Krozingen, Germany; (2) Department of Cardiac Surgery, Heart Centre Bad Krozingen, Germany; (3) Department of Clinical Pharmacology, Heart Centre Bad Krozingen, Germany

(1) Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands; (2) Department Molecular Medicine and Surgery, Section of Integrative Physiology, Karolinska Institutet, Stockholm, Sweden; (3) Department Molecular Medicine and Surgery, Karolinska Institutet, and Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden; (4) Department Physiology and Pharmacology, Section of Integrative Physiology, Karolinska Institutet, Stockholm, Sweden

(1) Department of Biochemistry and Molecular Biology, University of Athens, Panepistimiopolis, Athens, Greece; (2) Oncological Hospital “G.Gennimatas” IKA-ETAM of Athens, Athens, Greece

(1) CIBER de Enfermedades Raras (CIBERER), Madrid, Spain; (2) Department of Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain